<?xml version="1.0" encoding="UTF-8"?>
<p id="par0040">Given this evidence, the article itself recommended the use of chloroquine phosphate in patients with COVID-19,
 <xref rid="bib0160" ref-type="bibr">
  <sup>9</sup>
 </xref> a recommendation which was added that same day to the Chinese National Plan for Diagnosis and Treatment, version number 6, where it appears as first-line antiviral treatment, in a dose of 500Â mg orally 2 times a day for 7 days.
 <xref rid="bib0165" ref-type="bibr">
  <sup>10</sup>
 </xref>
</p>
